| pubmed-article:1331345 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C0034380 | lld:lifeskim |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C1527390 | lld:lifeskim |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C0206065 | lld:lifeskim |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C1518965 | lld:lifeskim |
| pubmed-article:1331345 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:1331345 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1331345 | pubmed:dateCreated | 1992-12-3 | lld:pubmed |
| pubmed-article:1331345 | pubmed:abstractText | This prospective clinical trial (1983-1989) compares life-quality scores according to Karnofsky in patients with intra-cranial who had been operated upon. Karnofsky's performance status was evaluated during a follow-up period of 36 months. The patients were between 20 to 77 years of age; 132 patients had an astrocytoma grade III or IV; 42 patients with brain metastases were investigated; 72 had an astrocytoma grade I + II, and 144 had a meningioma. The median survival in patients with astrocytomas grade III or IV was 12 months; a short period with nearly normal activity (Karnofsky score 75) was followed by rapid deterioration. In patients with brain metastases, postoperatively the median functional ability reached its highest value three weeks after treatment and then decreased continuously (average score from 50-25). In patients with astrocytomas grade I and II, life-quality was reasonably good (mean score up to 75). The score was observed to increase slightly during the first year after treatment. A performance status improvement up to 80 could be obtained in patients with meningiomas; however, 35% were left unfit for work. | lld:pubmed |
| pubmed-article:1331345 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1331345 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1331345 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1331345 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1331345 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:1331345 | pubmed:issn | 0167-594X | lld:pubmed |
| pubmed-article:1331345 | pubmed:author | pubmed-author:Sachsenheimer... | lld:pubmed |
| pubmed-article:1331345 | pubmed:author | pubmed-author:PiotrowskiWW | lld:pubmed |
| pubmed-article:1331345 | pubmed:author | pubmed-author:BimmlerTT | lld:pubmed |
| pubmed-article:1331345 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1331345 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:1331345 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1331345 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1331345 | pubmed:pagination | 177-81 | lld:pubmed |
| pubmed-article:1331345 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:meshHeading | pubmed-meshheading:1331345-... | lld:pubmed |
| pubmed-article:1331345 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1331345 | pubmed:articleTitle | Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. | lld:pubmed |
| pubmed-article:1331345 | pubmed:affiliation | Fakultät für klinische Medizin Mannheim, Universität Heidelberg, Germany. | lld:pubmed |
| pubmed-article:1331345 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1331345 | lld:pubmed |
